Skip to main content
Equibles
LGVN logo

LGVN · Longeveron Inc. · Earnings Call Transcripts & Audio

Track LGVN — free

Use LGVN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LGVN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.69 -0.03 (-1.10%) At close · Sep 30
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We have prepared a cash flow forecast which indicates that we do not have sufficient cash to meet our minimum expenditure commitments for one year from the date these financial statements are available to be issued and therefore we need to raise additional funds to continue as a going concern. As a result, there is substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Market Cap
$8.96M
Shares
3.19M
Volume · Sep 30 54.97K Avg daily vol (24 sessions) 165.5K

Longeveron Inc. Earnings Call Transcripts

Quarterly earnings calls for Longeveron Inc. (LGVN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲14.2% $265,000 −$5.24M '22 Q3 22-11-14 ▼42.1% $121,000 −$4.46M '22 Q4 23-03-10 ▼24.6% $279,000 −$4.65M '23 Q1 23-05-12 ▼53.4% $217,000 −$5.63M '23 Q2 23-06-30 ▼43.4% $150,000 −$5.11M '23 Q3 23-11-10 ▼47.9% $63,000 −$6.03M '23 Q4 24-02-27 ▲96.4% $548,000 −$4.06M '24 Q1 24-05-14 ▲115.7% $468,000 −$3.41M '24 Q2 24-08-14 ▲415.3% $773,000 −$4.42M '24 Q3 24-11-12 ▲857.1% $603,000 −$4.08M '24 Q4 25-02-28 ▼30.5% $381,000 −$5.01M '25 Q1 25-05-08 ▼32.5% $316,000 −$5.03M '25 Q2 25-08-13 ▼82.3% $137,000 −$7.22M '25 Q3 25-11-04 ▼39.5% $365,000 −$5.44M '25 Q4 26-03-17 ▲4.5% $398,000 −$4.74M '26 Q1 26-05-13 LATEST ▼9.2% $287,000 −$6.07M '26 Q2 26-08-12
Earnings call
FY26 · Q2
2026-08-12
Longeveron Inc. (LGVN) Q2 2026 Earnings Call Transcript
Confident tone Regulatory pathway and FDA engagement ELPIS-2 HLHS Phase 2B data readout External validation and XPRIZE recognition
Revenue
$287,000
▼ 9.2% YoY
Diluted EPS
$-1.90
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Longeveron Inc. (LGVN) Q1 2026 Earnings Call Transcript
Positive tone PDCM program progression ELPIS-2 HLHS readout Pipeline breadth beyond HLHS
Revenue
$398,000
▲ 4.5% YoY
Diluted EPS
$-1.90
Gross margin
66.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Longeveron Inc. (LGVN) Q4 2025 Earnings Call Transcript
Confident tone ELPIS II HLHS Pivotal Trial Pediatric Dilated Cardiomyopathy (PDCM) Priority Review Voucher (PRV)
Revenue
$365,000*
▼ 39.5% YoY
Gross margin
70.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Longeveron Inc. (LGVN) Q3 2025 Earnings Call Transcript
Balanced tone BLA preparedness and timeline slip ELPIS-2 / HLHS pivotal trial Pipeline breadth and other indications
Revenue
$137,000
▼ 82.3% YoY
Diluted EPS
$-3.90
Gross margin
91.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Longeveron Inc. (LGVN) Q2 2025 Earnings Call Transcript
Confident tone iPSC technology platform / differentiation Pediatric dilated cardiomyopathy pipeline expansion Alzheimer's disease program and partnership strategy
Revenue
$316,000
▼ 32.5% YoY
Diluted EPS
$-3.30
Gross margin
46.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Longeveron Inc. (LGVN) Q1 2025 Earnings Call
Revenue
$381,000
▼ 30.5% YoY
Diluted EPS
$-3.40
Gross margin
72.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Longeveron Inc. (LGVN) Q4 2024 Earnings Call Transcript
Confident tone HLHS (Hypoplastic Left Heart Syndrome) Program Alzheimer's Disease Program Laromestrocel / Lomecel-B Naming and Pipeline
Revenue
$603,000*
▲ 857.1% YoY
Gross margin
87.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Longeveron Inc. (LGVN) Q3 2024 Earnings Call Transcript
Confident tone HLHS / ELPIS II pivotal trial Alzheimer's disease program (CLEAR MIND) ELPIS I long-term follow-up data
Revenue
$773,000
▲ 415.3% YoY
Diluted EPS
$-3.40
Gross margin
88.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Longeveron Inc. (LGVN) Q2 2024 Earnings Call Transcript
Confident tone Pipeline and future strategy (Longeveron 2.0) HLHS (Hypoplastic Left Heart Syndrome) program Alzheimer's disease program
Revenue
$468,000
▲ 115.7% YoY
Diluted EPS
$-18.30
Gross margin
73.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
Confident tone Alzheimer's Disease Program Upcoming Catalysts and Pipeline HLHS Program (ELPIS II)
Revenue
$548,000
▲ 96.4% YoY
Diluted EPS
$-16.10
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Longeveron Inc. (LGVN) Q4 2023 Earnings Call Transcript
Confident tone HLHS / ELPIS Program Lead Priority Alzheimer's / CLEAR MIND Trial ELPAS II Enrollment Progress and Plans
Revenue
$63,000*
▼ 47.9% YoY
Gross margin
-3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-10
Longeveron Inc. (LGVN) Q3 2023 Earnings Call Transcript
Revenue
$150,000
▼ 43.4% YoY
Diluted EPS
$-27.90
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Longeveron Inc. (LGVN) Q2 2023 Earnings Call Transcript
Revenue
$217,000
▼ 53.4% YoY
Diluted EPS
$-26.70
Gross margin
42.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-12
Longeveron Inc. (LGVN) Q1 2023 Earnings Call Transcript
Revenue
$279,000
▼ 24.6% YoY
Diluted EPS
$-22.10
Gross margin
27.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-10
Longeveron Inc. (LGVN) Q4 2022 Earnings Call Transcript
Revenue
$121,000*
▼ 42.1% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Longeveron Inc. (LGVN) Q3 2022 Earnings Call Transcript
Revenue
$265,000
▲ 14.2% YoY
Diluted EPS
$-25.00
Gross margin
34.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
Longeveron Inc. (LGVN) Q2 2022 Earnings Call Transcript
Revenue
$466,000
▼ 4.7% YoY
Diluted EPS
$-27.00
Gross margin
34.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-13
Longeveron Inc. (LGVN) Q1 2022 Earnings Call Transcript
Revenue
$370,000
▼ 1.6% YoY
Diluted EPS
$-17.00
Gross margin
44.6%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-11
Longeveron Inc. (LGVN) Q4 2021 Earnings Call Transcript
Revenue
$209,000*
▼ 82.3% YoY
Gross margin
33.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Longeveron Inc. (LGVN) Q3 2021 Earnings Call Transcript
Revenue
$232,000
▼ 87.6% YoY
Diluted EPS
$-25.00
Gross margin
70.7%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-13
Longeveron Inc. (LGVN) Q2 2021 Earnings Call Transcript
Revenue
$489,000
▼ 44.2% YoY
Diluted EPS
$-26.00
Gross margin
42.5%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-14
Longeveron Inc. (LGVN) Q1 2021 Earnings Call Transcript
Revenue
$376,000
▼ 78% YoY
Gross margin
39.6%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-30
Longeveron Inc. (LGVN) Q4 2020 Earnings Call Transcript
Revenue
$1.18M*
Gross margin
44.8%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–23 of 23 earnings calls
Key facts CIK 1721484 CUSIP 54303L302 13F (30d) 1 filings 1 filers Visit website Investor relations